Related Experiment Video
Updated: Jul 15, 2026

Standardized Technique of Aortic Valve Re-implantation for Valve-sparing Aortic Root Replacement
Published on: December 11, 2017
Aortic valve replacement in octogenarians: risk factors for early and late mortality
Spencer J Melby1, Andreas Zierer, Scott P Kaiser
1Division of Cardiothoracic Surgery, Department of Surgery, Washington University School of Medicine and Barnes-Jewish Hospital, St. Louis, Missouri 63110, USA.
Insights
Aortic valve replacement (AVR) in patients 80 and older shows acceptable survival. Concomitant coronary artery bypass grafting (CABG) improves outcomes, suggesting aggressive surgical treatment is warranted for this elderly population.
Area of Science:
- Cardiovascular Surgery
- Geriatric Medicine
- Thoracic Surgery
Background:
- Elderly patients (80+ years) undergoing aortic valve replacement (AVR) can achieve excellent outcomes.
- Some clinicians hesitate to refer elderly patients for AVR.
- This study investigates mortality risk factors in octogenarians undergoing AVR, with or without concomitant coronary artery bypass grafting (CABG).
Purpose of the Study:
- To analyze risk factors for operative and long-term mortality in patients aged 80 years and older undergoing AVR.
- To evaluate the impact of concomitant CABG on survival in this patient group.
- To determine if aggressive surgical intervention is appropriate for elderly patients requiring AVR.
Main Methods:
- Retrospective review of 245 patients (mean age 83.6 years) who underwent AVR between 1993 and 2005.
- Analysis included patients who had AVR with (n=140) or without CABG (n=105).
- Multivariate logistic regression, Kaplan-Meier survival estimates, and Cox proportional hazards analysis were used to identify mortality predictors.
Main Results:
- Operative mortality was 9%. Independent risk factors for operative mortality included postoperative renal failure, stroke, and intraaortic balloon pump (IABP) placement.
- Five-year survival was 56%. Factors decreasing long-term survival included regurgitant valve pathology, IABP, renal failure, and stroke.
- Concomitant CABG was protective against operative mortality and improved long-term survival. Preoperative NYHA classification did not impact survival.
Conclusions:
- Patients aged 80 and older have acceptable short-term and long-term survival after AVR, irrespective of NYHA class.
- Concomitant CABG significantly improved both operative and long-term survival in this elderly population.
- Aggressive surgical treatment, including AVR with or without CABG, is recommended for most octogenarian patients.
Background:
Excellent outcomes after aortic valve replacement (AVR) in elderly patients can be achieved, yet some practitioners are reticent to refer elderly patients for surgery. This study analyzed risk factors for mortality in patients aged 80 years and older undergoing AVR with or without concomitant coronary artery bypass grafting (CABG).
Methods:
A retrospective review was performed of 245 patients (129 women) with a mean age of 83.6 +/- 2.9 years who had AVR with (n = 140) or without CABG (n = 105) at a single institution from 1993 to 2005. Data were analyzed with a multivariate logistic regression for predictors of operative mortality, Kaplan-Meier estimates of survival, and a Cox multivariate proportional analysis of factors influencing long-term survival.
Results:
Mean preoperative New York Heart Association (NYHA) classification was 3.1 +/- 0.9, and 78% (192/245) of patients were classified as NYHA class III or IV. Operative (30-day) mortality was 9% (22/245). Independent risk factors for operative mortality included postoperative renal failure (odds ratio [OR], 20.9; 95% confidence interval [CI], 6.5 to 67.6; p < 0.001), postoperative permanent stroke (OR, 11.3; 95% CI, 1.7 to 75.1; p = 0.019), or intraoperative/postoperative intraaortic balloon pump (IABP) placement (OR, 14.9; 95% CI 2.9 to 75.8; p = 0.002). Survival after surgery was 82% (n = 183) at 1 year and 56% (n = 88) at 5 years. Prognostic factors for decreased long-term survival were regurgitant valve pathology (hazard ratio [HR], 6.0; 95% CI, 2.5 to 14.2; p = 0.002), intraoperative/postoperative IABP (HR, 2.9; 95% CI, 1.4 to 6.0; p = 0.010), postoperative renal failure (HR, 3.5, 95% CI, 2.2 to 5.7; p < 0.001), and postoperative stroke (HR, 7.0, 95% CI, 3.2 to 15.9; p < 0.001). Performing concomitant CABG was protective in terms of operative mortality (OR, 0.3; 95% CI, 0.09 to 0.83; p = 0.017) and improved long-term survival (HR, 0.7, 95% CI, 0.47 to 0.96; p = 0.020). Preoperative NYHA classification did not affect operative or long-term survival.
Conclusions:
Patients aged 80 years and older who undergo AVR have acceptable short-term and long-term survival regardless of NYHA status. Concomitant CABG improved operative and long-term survival in this population. Despite their increased age, aggressive surgical treatment is warranted for most patients.
More Related Videos
Related Concept Videos
Aortic Regurgitation III: Medical Management
Aortic Regurgitation I: Introduction
Aortic Regurgitation II: Clinical Features and Diagnostic Tests
Aortic Regurgitation IV: Nursing Management
Mitral Valve Prolapse II: Assessment and Management
Mitral Valve Prolapse I: Introduction

